Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Medical Laboratory Scientist

Biomedical Sciences · Ethiopia · 2025-07-09

Processing Time
411 days
Decision Date
2025-07-09
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research on the development and validation of diagnostic assays to accurately identify infectious pathogens. These assays are intended for point-of-care testing, disease outbreak surveillance, and supporting clinical vaccine and drug trials. The work aims to improve the speed and accuracy of pathogen detection to enhance disease management and public health protection.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on diagnostic assays for infectious pathogens was found to have substantial merit for its role in protecting public health and addressing urgent healthcare challenges.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, citation count, and international grant funding demonstrated he is well-positioned to succeed in his proposed research.

3 Balance of Interests Met

On balance, it was determined that the petitioner's contributions to molecular diagnostics and disease surveillance provide a benefit to the U.S. that outweighs the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 7 peer-reviewed journal articles and 195 citations, indicating substantial influence in the field. Evidence included 2 peer reviews for reputable journals and 5 papers ranking among the most highly cited in Clinical Medicine. The case was further supported by two expert recommendation letters and a history of securing international research grants.

Request for Evidence (RFE)

Successfully Addressed

The RFE challenged the national significance of the research and the petitioner's qualifications. The response provided additional evidence of the research's impact on U.S. healthcare and the petitioner's standing in the field.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the Endeavor

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 80 days 2022-04-21
The petitioner proposes to continue research on the application of immunological and point-of-care-based assays to develop low-cost tools for diagnosing infectious diseases. This work aims to mitigate the public health impact of infectious diseases through accessible diagnostic technology.
View Case

Lecturer

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
63 days 2023-02-22
The petitioner proposes to continue her research on investigating quality control techniques, in vitro diagnostic tests, and antiviral/antibacterial drugs. Her work focuses on developing novel approaches for combating emerging infectious diseases, specifically advancing PCR protocols and diagnostic procedures.
View Case

Research Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Georgia 68 days 2025-02-27
The petitioner proposes to develop diagnostic assays and platforms to study infectious viruses to enable rapid containment of emerging diseases. This work focuses on advancing tools for the detection of viral pathogens and supporting antiviral and vaccine efficacy testing.
View Case

Scientist

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
California 290 days 2025-02-18
The petitioner proposes to develop optimized in vitro diagnostic tools to provide preventative healthcare solutions and treatment strategies for cancer and infectious diseases. The work involves utilizing advanced molecular and cellular techniques to improve the accuracy, sensitivity, and specificity of diagnostic assays. This endeavor aims to improve early disease detection and reduce the management burden within the U.S. healthcare system.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Ethiopia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 411 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Ethiopia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist